Medicine and Dentistry
Patient
100%
T Cell
58%
Neoplasm
33%
Therapeutic Procedure
33%
Malignant Neoplasm
22%
Clear Cell Renal Cell Carcinoma
19%
Cells
18%
Inpatient
18%
Survival
15%
Development
15%
Tumor Antigen
14%
Chimeric Antigen Receptor T-Cell
14%
T Lymphocyte
13%
Vaccine
13%
Diseases
12%
Modified Vaccinia Virus Ankara 5T4 Vaccine
12%
Antigen
12%
Tumor Infiltrating Lymphocyte
12%
Cell Therapy
11%
Immune Response
11%
Toxicity
11%
Lymphocyte
11%
Antibody
10%
Carcinoembryonic Antigen
10%
Sunitinib
10%
Interleukin 2
10%
Receptor
10%
Immunotherapy
9%
Regulatory T Cell
9%
Comprehension
8%
Overall Survival
8%
Cytokine
8%
Kidney Metastasis
8%
Colorectal Cancer
8%
Metastatic Carcinoma
7%
Surgery
7%
Cancer Cell
7%
Cancer Vaccine
7%
Chimeric Antigen Receptor
7%
Peptide
7%
Gene
7%
In Vitro
7%
B-Cell Lymphoma
6%
Cancer Treatment
6%
Immune System
6%
Immune System Receptors
6%
Adverse Event
6%
Protein
6%
Antibody Response
5%
Kidney Cancer
5%
Immunology and Microbiology
Cells
15%
Modified Vaccinia Virus Ankara 5T4 Vaccine
10%
B Cell
9%
Survival
9%
Immunotherapy
8%
Gene
8%
T Cell Receptor
8%
Blood Product
8%
Modified Vaccinia Ankara
8%
Vaccine Efficacy
7%
Cytotoxic T-Cell
7%
Monospecific Antibody
7%
Regulatory T Cell
7%
Adenoviridae
7%
Carcinoembryonic Antigen
7%
Antigen
7%
Mouse
7%
Immune Receptors
7%
Immune Response
6%
Interferon Type I
6%
Chimeric Antigen Receptor T-Cell
5%
Carcinoma Cell
5%
Syngenic
5%
Peripheral Blood Lymphocyte
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
12%
Neoplasm
12%
Placebo
12%
Sunitinib
10%
Pazopanib
10%
Toxicity
9%
Kidney Metastasis
9%
Modified Vaccinia Virus Ankara 5T4 Vaccine
9%
Progression Free Survival
9%
Diseases
8%
Survival
8%
Overall Survival
8%
Adverse Event
7%
Tumor Antigen
7%
Vaccine
7%
Cancer Vaccine
7%
Renal Cell Carcinoma
6%
Clinical Trial
5%
Antigen
5%